RxDoctor Payments Data

Raymond Heller, MD

Family Medicine · Superior, NENPI 1124137039

Payments from drug & device makers

$1,073in general payments, 2019–2025

Across 60 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$232
  • Otsuka America Pharmaceutical, Inc.$155
  • Gilead$133
  • Abbott$76
  • Novo Nordisk$75
  • Amgen$70
  • plus $333 from 14 others

What the payments were for

  • Food & beverage$1,03096%
  • Education$434%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,073 in reported general payments places this provider in the 60th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$15,953
Medicare patients
45
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$30,606
RexultiBrexpiprazole21$29,803
JardianceEmpagliflozin27$17,395
MounjaroTirzepatide14$15,830
EliquisApixaban29$15,356
FarxigaDapagliflozin Propanediol12$13,495
Praluent PenAlirocumab14$7,074
Ventolin HfaAlbuterol Sulfate14$889
Albuterol Sulfate HfaAlbuterol Sulfate22$776
Tamsulosin Hcl54$675
Cefdinir40$661
Rosuvastatin Calcium33$618
Atorvastatin Calcium90$517
Omeprazole20$506
Levothyroxine Sodium42$403

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$75$30,60633 claims
Otsuka America Pharmaceutical, Inc.Rexulti$155$29,80321 claims
Lilly USA, LLCMounjaro$13$15,83014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 981 family medicine providers in Nebraska.

Other family medicine in Superior

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →